These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2703528)

  • 1. Lymphocyte proliferative responses to human immunodeficiency virus antigens in vitro.
    Krowka JF; Stites DP; Jain S; Steimer KS; George-Nascimento C; Gyenes A; Barr PJ; Hollander H; Moss AR; Homsy JM
    J Clin Invest; 1989 Apr; 83(4):1198-203. PubMed ID: 2703528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocyte proliferative responses to soluble and liposome-conjugated envelope peptides of HIV-1.
    Krowka J; Stites D; Debs R; Larsen C; Fedor J; Brunette E; Düzgünes N
    J Immunol; 1990 Apr; 144(7):2535-40. PubMed ID: 1969450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphocyte proliferative responses to HIV-1 envelope and core antigens by infected and uninfected adults and children.
    Borkowsky W; Krasinski K; Moore T; Papaevangelou V
    AIDS Res Hum Retroviruses; 1990 May; 6(5):673-8. PubMed ID: 2113821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant HIV structural proteins detect specific cellular immunity in vitro in infected individuals.
    Torseth JW; Berman PW; Merigan TC
    AIDS Res Hum Retroviruses; 1988 Feb; 4(1):23-30. PubMed ID: 2835070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell recognition of HIV synthetic peptides in a natural infection.
    Schrier RD; Gnann JW; Landes R; Lockshin C; Richman D; McCutchan A; Kennedy C; Oldstone MB; Nelson JA
    J Immunol; 1989 Feb; 142(4):1166-76. PubMed ID: 2783706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocytes from some long-term seronegative heterosexual partners of HIV-infected individuals proliferate in response to HIV antigens.
    Kelker HC; Seidlin M; Vogler M; Valentine FT
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1355-9. PubMed ID: 1466956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of interleukin 2 and large envelope glycoprotein (gp 120) of human immunodeficiency virus (HIV) on lymphocyte proliferative responses to cytomegalovirus.
    Krowka J; Stites D; Mills J; Hollander H; McHugh T; Busch M; Wilhelm L; Blackwood L
    Clin Exp Immunol; 1988 May; 72(2):179-85. PubMed ID: 2842093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody-dependent cellular cytotoxicity is directed against both the gp120 and gp41 envelope proteins of HIV.
    Evans LA; Thomson-Honnebier G; Steimer K; Paoletti E; Perkus ME; Hollander H; Levy JA
    AIDS; 1989 May; 3(5):273-6. PubMed ID: 2548535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular immune response to viral peptides in patients exposed to HIV.
    Ahearne PM; Matthews TJ; Lyerly HK; White GC; Bolognesi DP; Weinhold KJ
    AIDS Res Hum Retroviruses; 1988 Aug; 4(4):259-67. PubMed ID: 2462895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-clade immune responses after immunization with a whole-killed gp120-depleted human immunodeficiency virus type-1 immunogen in incomplete Freund's adjuvant (HIV-1 immunogen, REMUNE) in human immunodeficiency virus type-1 seropositive subjects.
    Moss RB; Giermakowska W; Lanza P; Turner JL; Wallace MR; Jensen FC; Theofan G; Richieri SP; Carlo DJ
    Viral Immunol; 1997; 10(4):221-8. PubMed ID: 9473153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of antibody recognition of selected conserved amino acid sequences from the HIV envelope in sera from different stages of HIV infection.
    Shafferman A; Lennox J; Grosfeld H; Sadoff J; Redfield RR; Burke DS
    AIDS Res Hum Retroviruses; 1989 Feb; 5(1):33-9. PubMed ID: 2541748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reliable confirmation of antibodies to human immunodeficiency virus type 1 (HIV-1) with an enzyme-linked immunoassay using recombinant antigens derived from the HIV-1 gag, pol, and env genes.
    Ng VL; Chiang CS; Debouck C; McGrath MS; Grove TH; Mills J
    J Clin Microbiol; 1989 May; 27(5):977-82. PubMed ID: 2787334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolate- and group-specific immune responses to the envelope protein of human immunodeficiency virus induced by a live recombinant vaccinia virus in macaques.
    Earl PL; Robert-Guroff M; Matthews TJ; Krohn K; London WT; Moss B
    AIDS Res Hum Retroviruses; 1989 Feb; 5(1):23-32. PubMed ID: 2541747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4+ lymphocyte function with early human immunodeficiency virus infection.
    Gurley RJ; Ikeuchi K; Byrn RA; Anderson K; Groopman JE
    Proc Natl Acad Sci U S A; 1989 Mar; 86(6):1993-7. PubMed ID: 2564677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a new dot blot assay for confirmation of human immunodeficiency virus type 1 and 2 infections using recombinant p24, gp41, gp120 and gp36 antigens.
    Ravanshad M; Sabahi F; Mahboudi F; Kazemnejad A
    Saudi Med J; 2006 Jan; 27(1):31-6. PubMed ID: 16432590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergism between HIV gp120 and gp120-specific antibody in blocking human T cell activation.
    Mittler RS; Hoffmann MK
    Science; 1989 Sep; 245(4924):1380-2. PubMed ID: 2571187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenic specificity of antibody-dependent cell-mediated cytotoxicity directed against human immunodeficiency virus in antibody-positive sera.
    Koup RA; Sullivan JL; Levine PH; Brewster F; Mahr A; Mazzara G; McKenzie S; Panicali D
    J Virol; 1989 Feb; 63(2):584-90. PubMed ID: 2536094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-mediated immune proliferative responses to HIV-1 of chimpanzees vaccinated with different vaccinia recombinant viruses.
    Van Eendenburg JP; Yagello M; Girard M; Kieny MP; Lecocq JP; Muchmore E; Fultz PN; Riviere Y; Montagnier L; Gluckman JC
    AIDS Res Hum Retroviruses; 1989 Feb; 5(1):41-50. PubMed ID: 2470398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early detection of antibodies against rDNA-produced HIV proteins with a flow cytometric assay.
    Scillian JJ; McHugh TM; Busch MP; Tam M; Fulwyler MJ; Chien DY; Vyas GN
    Blood; 1989 May; 73(7):2041-8. PubMed ID: 2540862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring human immunodeficiency virus type 1-infected patients by ratio of antibodies to gp41 and p24.
    Schmidt G; Amiraian K; Frey H; Wethers J; Stevens RW; Berns DS
    J Clin Microbiol; 1989 May; 27(5):843-8. PubMed ID: 2501350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.